• Research ›
• Research Base

Open, Closed, and Published Protocols

Open

• 98110: A Randomized Phase II Dose Finding Study of ArginMax with or without Phosphodiesterase-5 Inhibitors for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy (1 credit)
  Current Accrual: 131 out of 140 patients
• 99211: Feasibility of Delivering a Quitline Based Smoking Cessation Intervention in Cancer Patients Receiving Outpatient Treatment: A Pilot Study (1 Credit)
  Current Accrual: 73 out of 146 patients
• 99311: Randomized Placebo-Controlled Phase 2 Pilot Study of Memantine (Namenda) for Smoking Cessation among Cancer Survivors (1 credit)
  Current Accrual: 84 out of 130 patients

---

Closed

60A02 Juice Plus, Head and Neck Cancer

71103 Depsipeptide, Soft Tissue Sarcoma

91105 Donepezil, Brain Tumor Patients

97100 Donepezil/ Ginkgo Biloba, Brain Tumor Patients

91202 Thalidomide/Procarbazine, Gliomas

97106 ArginMax, Female Cancer Survivors

97102 Oxandrin/ Megace, Solid Tumor

97202 CoQ10, Breast Cancer

97211 Donepezil/ Breast Cancer Cognitive Dysfunction

97309 Yoga/ Wellness Education, Breast Cancer

97405 Soy/ Effexor, Prostate Patients

97509 Armodafinil/ Brain Radiation-Induced Fatigue

97609 Biomarkers/ Breast Cancer Radiosensitivity

98301 St. John's Wort, Breast Cancer

98308 COLD-fX, CLL

---

 Publications